mRNA Conference Europe 2026

Date: 22-23 July 2026
Venue: JW Marriott Hotel, Frankfurt, Germany
Registrations: Click here to reserve your place

The mRNA Conference Europe brings together leading scientists, biotech innovators, pharmaceutical companies, healthcare professionals, and investors to explore the future of mRNA technology and RNA-based therapeutics.

Partner Ross Cummings, from our life sciences and biotech team will be speaking in the session “Patent strategy for RNA therapeutics in Europe and US” on Thursday 23 July at 9:10.

In this session, attendees will gain expert insight into:

• The evolving patent landscape for RNA therapeutics, including the key differences between EU and US patent eligibility boundaries for RNA sequences and modifications.

• Effective claim structuring strategies across various RNA types, with approaches that combine sequence and chemical modifications to strengthen patent protection and commercial value.

• How to support inventions with the appropriate experimental evidence, including what data is required, when it should be presented, and how to build a robust patent application for successful prosecution and long-term intellectual property protection.

For full details and to book your place please visit the mRNA Conference Europe website.

Speaker

Ross Cummings is a European and UK chartered patent attorney with almost two decades of experience in the biotechnology industry, particularly in inventions relating to cell and gene therapy, immunology, genomics, microbiology, cancer therapeutics and drug delivery.

Ross has extensive expertise in patent drafting, global patent prosecution, product life cycle management, and strategic IP support for operational and investment decisions. He works with a broad range of clients, including universities, spin-outs, SMEs, investors, and multinational biotech companies across the UK and Europe.